A positive review of current and future chronic lymphocytic leukemia treatments
George Follows, MA, BM, BCh, PhD, FRCP, FRCPath from Cambridge University, Cambridge, UK provides us with an update on current and future chronic lymphocytic leukemia (CLL) treatments that have been presented at the 2016 American Society of Hematology (ASH) Annual Meeting, held in San Diego, CA. Prof. Follows begins by reviewing the positive results seen using currently available CLL drugs used on their own and in combination with other therapies. He also gives an update on the latest CLL trials, including those on venetoclax and new combination therapies. Prof. Follows provides an example of an exciting new trial testing alemtuzumab antibody treatment in combination with venetoclax. More CLL trials and drugs are in the pipeline and, while getting these treatments into practice will take time, the results will be worth it.
-
Category
No comments found